Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 241 to 252 of 252 entries
Sorted by: Best Match Show Resources per page
[(V.

Dalton transactions (Cambridge, England : 2003)

Fraser HWL, Payne EH, Sarkar A, Wilson LRB, Mitcov D, Nichol GS, Rajaraman G, Piligkos S, Brechin EK.
PMID: 34240723
Dalton Trans. 2021 Sep 21;50(36):12495-12501. doi: 10.1039/d1dt01710a.

Heterometallic Anderson wheels of formula [(V

Cite
Fraser HWL, Payne EH, Sarkar A, et al. [(V. Dalton Trans. 2021;50(36):12495-12501doi: 10.1039/d1dt01710a.
Fraser, H. W. L., Payne, E. H., Sarkar, A., Wilson, L. R. B., Mitcov, D., Nichol, G. S., Rajaraman, G., Piligkos, S., & Brechin, E. K. (2021). [(V. Dalton transactions (Cambridge, England : 2003), 50(36), 12495-12501. https://doi.org/10.1039/d1dt01710a
Fraser, Hector W L, et al. "[(V." Dalton transactions (Cambridge, England : 2003) vol. 50,36 (2021): 12495-12501. doi: https://doi.org/10.1039/d1dt01710a
Fraser HWL, Payne EH, Sarkar A, Wilson LRB, Mitcov D, Nichol GS, Rajaraman G, Piligkos S, Brechin EK. [(V. Dalton Trans. 2021 Sep 21;50(36):12495-12501. doi: 10.1039/d1dt01710a. PMID: 34240723.
Copy Download .nbib Format: NLM
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.

medRxiv : the preprint server for health sciences

Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF.
PMID: 34981068
medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485.

BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent serious complications of COVID-19 in outpatients with recent onset of illness is uncertain.METHODS: This multicenter, double-blind randomized controlled trial compared the efficacy and safety of SARS-CoV-2 high titer...

Cite
Sullivan DJ, Gebo KA, Shoham S, et al. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021;doi: 10.1101/2021.12.10.21267485.
Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, E. C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S. L., Casadevall, A., Tobian, A. A. R., & Hanley, D. F. (2021). Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.10.21267485
Sullivan, David J, et al. "Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.10.21267485
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485. PMID: 34981068; PMCID: PMC8722611.
Copy Download .nbib Format: NLM
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma.

medRxiv : the preprint server for health sciences

Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF.
PMID: 34981068
medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485.

BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent serious complications of COVID-19 in outpatients with recent onset of illness is uncertain.METHODS: This multicenter, double-blind randomized controlled trial compared the efficacy and safety of SARS-CoV-2 high titer...

Cite
Sullivan DJ, Gebo KA, Shoham S, et al. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021;doi: 10.1101/2021.12.10.21267485.
Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, E. C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S. L., Casadevall, A., Tobian, A. A. R., & Hanley, D. F. (2021). Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv : the preprint server for health sciences, . https://doi.org/10.1101/2021.12.10.21267485
Sullivan, David J, et al. "Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma." medRxiv : the preprint server for health sciences vol. (2021). doi: https://doi.org/10.1101/2021.12.10.21267485
Sullivan DJ, Gebo KA, Shoham S, Bloch EM, Lau B, Shenoy AG, Mosnaim GS, Gniadek TJ, Fukuta Y, Patel B, Heath SL, Levine AC, Meisenberg BR, Spivak ES, Anjan S, Huaman MA, Blair JE, Currier JS, Paxton JH, Gerber JM, Petrini JR, Broderick PB, Rausch W, Cordisco ME, Hammel J, Greenblatt B, Cluzet VC, Cruser D, Oei K, Abinante M, Hammitt LL, Sutcliffe CG, Forthal DN, Zand MS, Cachay ER, Raval JS, Kassaye SG, Foster EC, Roth M, Marshall CE, Yarava A, Lane K, McBee NA, Gawad AL, Karlen N, Singh A, Ford DE, Jabs DA, Appel LJ, Shade DM, Ehrhardt S, Baksh SN, Laeyendecker O, Pekosz A, Klein SL, Casadevall A, Tobian AAR, Hanley DF. Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma. medRxiv. 2021 Dec 21; doi: 10.1101/2021.12.10.21267485. PMID: 34981068; PMCID: PMC8722611.
Copy Download .nbib Format: NLM
The Phospha-Bora-Wittig Reaction.

Journal of the American Chemical Society

Borys AM, Rice EF, Nichol GS, Cowley MJ.
PMID: 34437805
J Am Chem Soc. 2021 Sep 08;143(35):14065-14070. doi: 10.1021/jacs.1c06228. Epub 2021 Aug 26.

We report the phospha-bora-Wittig reaction for the direct preparation of phosphaalkenes from aldehydes, ketones, esters, or amides. The transient phosphaborene Mes*P═B-NR

Cite
Borys AM, Rice EF, Nichol GS, et al. The Phospha-Bora-Wittig Reaction. J Am Chem Soc. 2021;143(35):14065-14070doi: 10.1021/jacs.1c06228.
Borys, A. M., Rice, E. F., Nichol, G. S., & Cowley, M. J. (2021). The Phospha-Bora-Wittig Reaction. Journal of the American Chemical Society, 143(35), 14065-14070. https://doi.org/10.1021/jacs.1c06228
Borys, Andryj M, et al. "The Phospha-Bora-Wittig Reaction." Journal of the American Chemical Society vol. 143,35 (2021): 14065-14070. doi: https://doi.org/10.1021/jacs.1c06228
Borys AM, Rice EF, Nichol GS, Cowley MJ. The Phospha-Bora-Wittig Reaction. J Am Chem Soc. 2021 Sep 08;143(35):14065-14070. doi: 10.1021/jacs.1c06228. Epub 2021 Aug 26. PMID: 34437805; PMCID: PMC8431359.
Copy Download .nbib Format: NLM
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis.

International journal of MS care

Salter A, Fox RJ, Cutter G, Marrie RA, Nichol KE, Steinerman JR, Smith KMJ.
PMID: 35035295
Int J MS Care. 2021 Nov-Dec;23(6):245-252. doi: 10.7224/1537-2073.2021-036. Epub 2021 Dec 29.

BACKGROUND: As cannabis products become increasingly accessible across the United States, it is important to understand the contemporary use of cannabis for managing multiple sclerosis (MS) symptoms.METHODS: We invited participants with MS from the North American Research Committee on...

Cite
Salter A, Fox RJ, Cutter G, et al. A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis. Int J MS Care. 2021;23(6):245-252doi: 10.7224/1537-2073.2021-036.
Salter, A., Fox, R. J., Cutter, G., Marrie, R. A., Nichol, K. E., Steinerman, J. R., & Smith, K. M. J. (2021). A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis. International journal of MS care, 23(6), 245-252. https://doi.org/10.7224/1537-2073.2021-036
Salter, Amber, et al. "A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis." International journal of MS care vol. 23,6 (2021): 245-252. doi: https://doi.org/10.7224/1537-2073.2021-036
Salter A, Fox RJ, Cutter G, Marrie RA, Nichol KE, Steinerman JR, Smith KMJ. A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis. Int J MS Care. 2021 Nov-Dec;23(6):245-252. doi: 10.7224/1537-2073.2021-036. Epub 2021 Dec 29. PMID: 35035295; PMCID: PMC8745229.
Copy Download .nbib Format: NLM
[Fe.

Chemical communications (Cambridge, England)

Cutler DJ, Singh MK, Nichol GS, Evangelisti M, Schnack J, Cronin L, Brechin EK.
PMID: 34396373
Chem Commun (Camb). 2021 Sep 06;57(71):8925-8928. doi: 10.1039/d1cc03919a.

The combination of two different Fe

Cite
Cutler DJ, Singh MK, Nichol GS, et al. [Fe. Chem Commun (Camb). 2021;57(71):8925-8928doi: 10.1039/d1cc03919a.
Cutler, D. J., Singh, M. K., Nichol, G. S., Evangelisti, M., Schnack, J., Cronin, L., & Brechin, E. K. (2021). [Fe. Chemical communications (Cambridge, England), 57(71), 8925-8928. https://doi.org/10.1039/d1cc03919a
Cutler, Daniel J, et al. "[Fe." Chemical communications (Cambridge, England) vol. 57,71 (2021): 8925-8928. doi: https://doi.org/10.1039/d1cc03919a
Cutler DJ, Singh MK, Nichol GS, Evangelisti M, Schnack J, Cronin L, Brechin EK. [Fe. Chem Commun (Camb). 2021 Sep 06;57(71):8925-8928. doi: 10.1039/d1cc03919a. PMID: 34396373.
Copy Download .nbib Format: NLM
Formation of a hydride containing amido-zincate using pinacolborane.

Dalton transactions (Cambridge, England : 2003)

Uzelac M, Yuan K, Nichol GS, Ingleson MJ.
PMID: 34546250
Dalton Trans. 2021 Oct 12;50(39):14018-14026. doi: 10.1039/d1dt02580e.

Amido-zincates containing hydrides are underexplored yet potentially useful complexes. Attempts to access this type of zincate through combining amido-organo zincates and pinacolborane (HBPin)

Cite
Uzelac M, Yuan K, Nichol GS, et al. Formation of a hydride containing amido-zincate using pinacolborane. Dalton Trans. 2021;50(39):14018-14026doi: 10.1039/d1dt02580e.
Uzelac, M., Yuan, K., Nichol, G. S., & Ingleson, M. J. (2021). Formation of a hydride containing amido-zincate using pinacolborane. Dalton transactions (Cambridge, England : 2003), 50(39), 14018-14026. https://doi.org/10.1039/d1dt02580e
Uzelac, Marina, et al. "Formation of a hydride containing amido-zincate using pinacolborane." Dalton transactions (Cambridge, England : 2003) vol. 50,39 (2021): 14018-14026. doi: https://doi.org/10.1039/d1dt02580e
Uzelac M, Yuan K, Nichol GS, Ingleson MJ. Formation of a hydride containing amido-zincate using pinacolborane. Dalton Trans. 2021 Oct 12;50(39):14018-14026. doi: 10.1039/d1dt02580e. PMID: 34546250; PMCID: PMC8507400.
Copy Download .nbib Format: NLM
An [FeIII30] molecular metal oxide.

Chemical communications (Cambridge, England)

Dearle AE, Cutler DJ, Coletta M, Lee E, Dey S, Sanz S, Fraser HWL, Nichol GS, Rajaraman G, Schnack J, Cronin L, Brechin EK.
PMID: 34807967
Chem Commun (Camb). 2021 Dec 21;58(1):52-55. doi: 10.1039/d1cc06224g.

Dissolution of FeBr

Cite
Dearle AE, Cutler DJ, Coletta M, et al. An [FeIII30] molecular metal oxide. Chem Commun (Camb). 2021;58(1):52-55doi: 10.1039/d1cc06224g.
Dearle, A. E., Cutler, D. J., Coletta, M., Lee, E., Dey, S., Sanz, S., Fraser, H. W. L., Nichol, G. S., Rajaraman, G., Schnack, J., Cronin, L., & Brechin, E. K. (2021). An [FeIII30] molecular metal oxide. Chemical communications (Cambridge, England), 58(1), 52-55. https://doi.org/10.1039/d1cc06224g
Dearle, Alice E, et al. "An [FeIII30] molecular metal oxide." Chemical communications (Cambridge, England) vol. 58,1 (2021): 52-55. doi: https://doi.org/10.1039/d1cc06224g
Dearle AE, Cutler DJ, Coletta M, Lee E, Dey S, Sanz S, Fraser HWL, Nichol GS, Rajaraman G, Schnack J, Cronin L, Brechin EK. An [FeIII30] molecular metal oxide. Chem Commun (Camb). 2021 Dec 21;58(1):52-55. doi: 10.1039/d1cc06224g. PMID: 34807967.
Copy Download .nbib Format: NLM
Reversible Dissociation of a Dialumene*.

Angewandte Chemie (International ed. in English)

Falconer RL, Byrne KM, Nichol GS, Krämer T, Cowley MJ.
PMID: 34520616
Angew Chem Int Ed Engl. 2021 Nov 08;60(46):24702-24708. doi: 10.1002/anie.202111385. Epub 2021 Oct 07.

Dialumenes are neutral Al

Cite
Falconer RL, Byrne KM, Nichol GS, et al. Reversible Dissociation of a Dialumene*. Angew Chem Int Ed Engl. 2021;60(46):24702-24708doi: 10.1002/anie.202111385.
Falconer, R. L., Byrne, K. M., Nichol, G. S., Krämer, T., & Cowley, M. J. (2021). Reversible Dissociation of a Dialumene*. Angewandte Chemie (International ed. in English), 60(46), 24702-24708. https://doi.org/10.1002/anie.202111385
Falconer, Rosalyn L, et al. "Reversible Dissociation of a Dialumene*." Angewandte Chemie (International ed. in English) vol. 60,46 (2021): 24702-24708. doi: https://doi.org/10.1002/anie.202111385
Falconer RL, Byrne KM, Nichol GS, Krämer T, Cowley MJ. Reversible Dissociation of a Dialumene*. Angew Chem Int Ed Engl. 2021 Nov 08;60(46):24702-24708. doi: 10.1002/anie.202111385. Epub 2021 Oct 07. PMID: 34520616; PMCID: PMC8596890.
Copy Download .nbib Format: NLM
Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma.

Thorax

Pathinayake PS, Waters DW, Nichol KS, Brown AC, Reid AT, Hsu AC, Horvat JC, Wood LG, Baines KJ, Simpson JL, Gibson PG, Hansbro PM, Wark PAB.
PMID: 34510013
Thorax. 2021 Sep 11; doi: 10.1136/thoraxjnl-2020-215979. Epub 2021 Sep 11.

INTRODUCTION: The significance of endoplasmic reticulum (ER) stress in asthma is unclear. Here, we demonstrate that ER stress and the unfolded protein response (UPR) are related to disease severity and inflammatory phenotype.METHODS: Induced sputum (n=47), bronchial lavage (n=23) and...

Cite
Pathinayake PS, Waters DW, Nichol KS, et al. Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma. Thorax. 2021;doi: 10.1136/thoraxjnl-2020-215979.
Pathinayake, P. S., Waters, D. W., Nichol, K. S., Brown, A. C., Reid, A. T., Hsu, A. C., Horvat, J. C., Wood, L. G., Baines, K. J., Simpson, J. L., Gibson, P. G., Hansbro, P. M., & Wark, P. A. B. (2021). Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma. Thorax, . https://doi.org/10.1136/thoraxjnl-2020-215979
Pathinayake, Prabuddha S, et al. "Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma." Thorax vol. (2021). doi: https://doi.org/10.1136/thoraxjnl-2020-215979
Pathinayake PS, Waters DW, Nichol KS, Brown AC, Reid AT, Hsu AC, Horvat JC, Wood LG, Baines KJ, Simpson JL, Gibson PG, Hansbro PM, Wark PAB. Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma. Thorax. 2021 Sep 11; doi: 10.1136/thoraxjnl-2020-215979. Epub 2021 Sep 11. PMID: 34510013.
Copy Download .nbib Format: NLM
Cloning, pharmacological characterization and distribution of a novel galanin receptor .

Brain research. Molecular brain research

Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA, Pine KA, Wang J, Goldstein ME, Iismaa TP, Zimanyi IA.
PMID: 9473722
Brain Res Mol Brain Res. 1998 Jan;53(1):348. doi: 10.1016/s0169-328x(97)00359-8.

No abstract available.

Cite
Fathi Z, Cunningham AM, Iben LG, et al. Cloning, pharmacological characterization and distribution of a novel galanin receptor . Brain Res Mol Brain Res. 1998;53(1):348doi: 10.1016/s0169-328x(97)00359-8.
Fathi, Z., Cunningham, A. M., Iben, L. G., Battaglino, P. B., Ward, S. A., Nichol, K. A., Pine, K. A., Wang, J., Goldstein, M. E., Iismaa, T. P., & Zimanyi, I. A. (1998). Cloning, pharmacological characterization and distribution of a novel galanin receptor . Brain research. Molecular brain research, 53(1), 348. https://doi.org/10.1016/s0169-328x(97)00359-8
Fathi, et al. "Cloning, pharmacological characterization and distribution of a novel galanin receptor ." Brain research. Molecular brain research vol. 53,1 (1998): 348. doi: https://doi.org/10.1016/s0169-328x(97)00359-8
Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA, Pine KA, Wang J, Goldstein ME, Iismaa TP, Zimanyi IA. Cloning, pharmacological characterization and distribution of a novel galanin receptor . Brain Res Mol Brain Res. 1998 Jan;53(1):348. doi: 10.1016/s0169-328x(97)00359-8. PMID: 9473722.
Copy Download .nbib Format: NLM
Promoting STEM education in community college students via research.

Crawford CA, Nichol CA, Obenland C, Chow A, Avendano C.
UIID-AD: 4848
2017;

The REU (research experience for undergraduates) can be a formative and beneficial experience for students in STEM (Science, Technology, Engineering and Math) majors. These programs most often select the top undergraduate students to perform research at prestigious universities. The...

Cite
Crawford CA, Nichol CA, Obenland C, et al. Promoting STEM education in community college students via research. 2017;
Crawford, C. A., Nichol, C. A., Obenland, C., Chow, A., & Avendano, C. (2017). Promoting STEM education in community college students via research. .
Crawford, C A, et al. "Promoting STEM education in community college students via research." vol. (2017).
Crawford CA, Nichol CA, Obenland C, Chow A, Avendano C. Promoting STEM education in community college students via research. 2017; UIID-AD: 4848.
Copy Download .nbib Format: NLM
Showing 241 to 252 of 252 entries